SEARCH

SEARCH BY CITATION

References

  • 1
    Cole SG, Otto CM, Hughes D. Cardiopulmonary cerebral resuscitation in small animals – a clinical practice review. Part I. J Vet Emerg Crit Care 2002;12:261267.
  • 2
    Cole SG, Otto CM, Hughes D. Cardiopulmonary resuscitation in small animals – a clinical practice review. Part II. J Vet Emerg Crit Care 2003;13:1323.
  • 3
    Plunkett SJ, McMichael M. Cardiopulmonary resuscitation in small animal medicine: An update. J Vet Intern Med 2008;22:925.
  • 4
    Kass PH, Haskins SC. Survival following cardiopulmonary resuscitation in dogs and cats. J Vet Emerg Crit Care 1992;2:5765.
  • 5
    Wingfield WE, Van Pelt DR. Respiratory and cardiopulmonary arrest in dogs and cats: 265 cases (1986-1991). J Am Vet Med Assoc 1992;200:19931996.
  • 6
    Rush JE, Wingfield WE. Recognition and frequency of dysrhythmias during cardiopulmonary arrest. J Am Vet Med Assoc 1992;200:19321937.
  • 7
    Waldrop JE, Rozanski EA, Swanke ED, et al. Causes of cardiopulmonary arrest, resuscitation management, and functional outcome in dogs and cats surviving cardiopulmonary arrest. J Vet Emerg Crit Care 2004;14:2229.
  • 8
    Hofmeister EH, Brainard BM, Egger CM, Kang S. Prognostic indicators for dogs and cats with cardiopulmonary arrest treated by cardiopulmonary cerebral resuscitation at a university teaching hospital. J Am Vet Med Assoc 2009;235:5057.
  • 9
    American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2010;122(Suppl):640656.
  • 10
    Perondi MBM, Reis AG, Paiva EF, et al. A comparison of high-dose and standard-dose epinephrine in children with cardiac arrest. N Engl J Med 2004;350:17221730.
  • 11
    Rubertson S, Grenvik A, Zemgulis V, et al. Systemic perfusion pressure and blood flow before and after administration of epinephrine during experimental cardiopulmonary resuscitation. Crit Care Med 1995;23:19841996
  • 12
    Behringer W, Kittler H, Sterz F, et al. Cumulative epinephrine dose during cardiopulmonary resuscitation and neurologic outcome. Ann Intern Med 1998;129:450456.
  • 13
    Tang W, Weil MH, Sun S, et al. Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation 1995;92:30893093.
  • 14
    Tang W, Weil MH, Gazmuri RJ, et al. Pulmonary ventilation/perfusion defects induced by epinephrine during cardiopulmonary resuscitation. Circulation 1991;84:21012107.
  • 15
    Lindner KH, Haak T, Keller A, et al. Release of endogenous vasopressors during and after cardiopulmonary resuscitation. Heart 1996;75:145150.
  • 16
    Paradis NA, Rose MI, Garg U. The effect of global ischemia and reperfusion on the plasma levels of vasoactive peptides. The neurohormonal response to cardiac arrest and resuscitation. Resuscitation 1993;26:261269.
  • 17
    Lindner KH, Strohmenger HU, Ensinger H, et al. Stress hormone response during and after cardiopulmonary resuscitation. Anesthesiology 1992;77:662668.
  • 18
    Lindner KH, Prengel AW, Pfenninger EG. Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs. Circulation 1995;91:215221.
  • 19
    Baber SI, Berg RA, Hilwig RW, et al. Vasopressin versus epinephrine during cardiopulmonary resuscitation: A randomized swine outcome study. Resuscitation 1999;41:185192.
  • 20
    Wenzel V, Kern KB, Hilwig RW, et al. Effects of intravenous arginine vasopressin on epicardial coronary artery cross sectional area in a swine resuscitation model. Resuscitation 2005;64:219226.
  • 21
    Guyette FX, Guimond GE, Hostler D, et al. Vasopressin administered with epinephrine is associated with a return of a pulse in out-of-hospital cardiac arrest. Resuscitation 2004;63:277282.
  • 22
    Wenzel V, Krismer AC, Arntz HR, et al. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 2004;350:105113.
  • 23
    Biondi-Zoccai GGL, Abbate A, Parisi Q, et al. Is vasopressin superior to adrenaline or placebo in the management of cardiac arrest? A meta-analysis. Resuscitation 2003;59:221224.
  • 24
    Scroggin RD, Quandt J. The use of vasopressin for treating vasodilatory shock and cardiopulmonary arrest. J Vet Emerg Crit Care 2009;19:145157.
  • 25
    Trissel LA (ed). Handbook of Injectable Drugs, 16th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2011:591.
  • 26
    Idris AH, Becker LB, Ornato JP, et al. Utstein-style guidelines for uniform reporting of laboratory CPR research. A statement for healthcare professionals from a Task Force of the American Heart Association, the American College of Emergency Physicians, the American College of Cardiology, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, the Institute of Critical Care Medicine, the Safar Center for Resuscitation Research, and the Society for Academic Emergency Medicine. Resuscitation 1996;33:6984.
  • 27
    Jacobs I, Nadkarni V, Bahr J. Cardiac arrest and cardiopulmonary resuscitation outcome reports: Update and simplification of the Utstein templates for resuscitation registries: A statement for healthcare professionals from a task force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian Resuscitation Council, New Zealand Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Councils of Southern Africa). Circulation 2004;110:33853397.
  • 28
    Stadlbauer KH, Wagner-Berger HG, Wenzel V. Survival with full neurological recovery after prolonged cardiopulmonary resuscitation with a combination of vasopressin and epinephrine in pigs. Anesth Analg 2006;96:17431749.
  • 29
    Mann K, Berg R, Nadkarni V. Beneficial effects of vasopressin in prolonged pediatric cardiac arrest: A case series. Resuscitation 2002;52:149156.
  • 30
    59th World Medical Assocation Declaration of Helskinki, WMA Ferney -Volaire, France. Seoul, Korea, 2008. Available at: http://www.wma.net/en/30publications/10policies/b3/index.html. Accessed September 16, 2010.